The AACI Clinical Research Innovation (CRI) Steering Committee is currently soliciting abstracts for the 12th Annual AACI CRI Meeting that will be held July 7-9 in Chicago. This year’s meeting will focus on the future of cancer clinical research. The purpose of the abstracts is to inform meeting attendees about clinical trials office challenges and solutions implemented at AACI cancer centers.
This year, AACI has updated the abstract submission categories to the following topics: Regulatory, Training & Quality Assurance, Finance/CCSG/PRMS, Trial Recruitment & Community Outreach and Engagement, Trial Start-up, Clinical Operations, and Investigator-Initiated Trials. As in 2019, abstracts can be submitted online beginning in February. In the meantime, you may draft your abstract using the abstract template.
Three abstracts will be selected for oral presentation at the meeting. Up to two authors of each winning abstract will receive complimentary meeting registration or a refund for a previously paid meeting registration fee. While AACI encourages collaboration with external organizations, only employees of AACI member cancer centers are eligible for complimentary meeting registration.
All authors who submit abstracts are encouraged to present a poster and discuss their findings during the poster session at the meeting. Information about the poster session is forthcoming.
January 2, 2020
Abstract requirements available
February 3, 2020
Online submission tool opens
March 16, 2020 | 5:00 PM PT
Deadline to submit abstracts
Abstracts selected for oral presentation notifications sent to submitting authors
May 15, 2020
Deadline to submit an electronic copy of your poster to email@example.com